Marc Casper contends Thermo Fisher’s pharma and biotech customers will be able to navigate the Trump administration’s MFN drug pricing framework and tariffs.
The New Jersey-based CDMO is expanding its Charles City, Iowa site to boost large-scale active pharmaceutical ingredient production and meet rising peptide demand.
Join industry specialists as they share their insights, experiences, and strategies to enhance efficiency, reduce costs, and improve product quality in the production of non-traditional mAbs
